TMCnet News

Research and Markets: Dementia Therapeutics Pipeline Review 2015 - 33 Companies & 56 Drug Profiles
[February 26, 2015]

Research and Markets: Dementia Therapeutics Pipeline Review 2015 - 33 Companies & 56 Drug Profiles


Research and Markets (http://www.researchandmarkets.com/research/v9cd6d/dementia) has announced the addition of the "Dementia - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dementia and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Actinogen Limited
  • Alector LLC
  • AlzProtect SAS (News - Alert)
  • BioArctic Neuroscience AB
  • Biogen Idec Inc.
  • Biotie Therapies Corp.
  • Bristol-Myers Squibb Company
  • Chase Pharmaceuticals Corporation
  • Chronos Therapeutics Limited
  • Daewoong Pharmaceutical Co., Ltd.
  • Echo Pharmaceuticals B.V.
  • Eisai Co., Ltd.
  • FORUM Pharmaceuticals Inc.
  • Hyundai Pharmaceutical Co., Ltd.
  • Ildong Pharmaceutical Co., Ltd.
  • IMMD Inc.
  • ImStar Therapeutics Inc.
  • Integrative Research Laboratories Sweden AB
  • Intellect (News - Alert) Neurosciences, Inc.
  • Intra-Cellular Therapies, Inc.
  • Neurimmune Holding AG
  • Oryzon Genomics S.A.
  • Otsuka Holdings Co., Ltd.
  • Pacific Northwest Biotechnology, LLC
  • ProteoTech, Inc.
  • SK Chemicals Co., Ltd.
  • Stelic Institute & Co.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Sylentis S.A.
  • TauRx Therapeutics Ltd.



Drug Profiles

  • Antisense Oligonucleotide to Inhibit microRNA for Neurology
  • aripiprazole
  • AVCRI-104P3
  • AZP-2006
  • brexpiprazole
  • choline alfoscerate SR
  • CPC (News - Alert)-201
  • CPC-252
  • dehydroevodiamine hydrochloride
  • dronabinol
  • Drugs for Dementia
  • Drugs to Agonize c-MET for Dementia
  • Drugs to Inhibit Matrix Metalloproteinase for Dementia and Cognitive Impairment
  • DWJ-1365
  • E-2609
  • encenicline hydrochloride
  • FRM-0334
  • GIBH-130
  • gugulipid
  • IIPP-1
  • IMD-4482
  • IPN-007
  • IRL-752
  • ITI-007
  • KR-12
  • Monoclonal Antibodies for Dementia and Alzheimer's Disease
  • Monoclonal Antibodies to Inhibit Tau for CNS Disorders
  • NAT
  • NI-205
  • NI-308

For more information visit http://www.researchandmarkets.com/research/v9cd6d/dementia



[ Back To TMCnet.com's Homepage ]